Body mass index impacts the choice of lipid ‐lowering treatment with no correlation to blood cholesterol – Findings from 52 916 patients in the Dyslipidemia International Study (DYSIS)
Diabetes, Obesity and Metabolism, EarlyView.
Source: Diabetes, Obesity and Metabolism - Category: Endocrinology Authors: Jean
Ferri ères
MD
,
Dominik
Lautsch
MD
,
Anselm K.
Gitt
MD
,
Gaetano
De Ferrari
MD
,
Hermann
Toplak
MD
,
Moses
Elisaf
MD
,
Heinz
Drexel
MD
,
Martin
Horack
MSc
,
Carl
Baxter
MD
,
Baishali
Ambegaonkar
MD
,
Philippe Source Type: research
More News: Cholesterol | Diabetes | Eating Disorders & Weight Management | Endocrinology | Obesity | Study